Kodal Minerals clarifies Hainan resource estimate claims

Hainan reported an additional 15.47 million tonnes of spodumene resources at the Bougouni Lithium Project, but Kodal says that estimate is an internal, unverified figure and not JORC-compliant. Kodal holds 49% of KMUK (Hainan 51%), with KMUK holding a 65% interest in the 350 km2 Bougouni project; Stage 1 produced first spodumene concentrate in Feb 2025 with a 125,000 tpa Li2O target. Kodal warns any JORC-compliant resource increase requires geological interpretation and independent audit and is not expected in the short term, so treat the 15.47 Mt number as unconfirmed.

Analysis

Kodal’s situation is a classic disclosure/verification mismatch: an internal, non-JORC partner estimate creates a two-stage informational event stream (initial headline, then independent audit/JORC confirmation or rebuttal). In the near term (days–weeks) headlines drive volatility and retail momentum; in the medium term (3–12 months) the market will reprice based on whether an independent audit (and any subsequent resource upgrade) actually emerges and how that changes mine life, capital intensity and stage expansion economics.

Second-order supply-chain effects matter: if the partner’s numbers are ultimately validated, the asset could shift from a single-stage feedstock supplier to a multi-stage spodumene source, pressuring spot spodumene premiums in a 12–36 month window but also attracting offtake/financing from vertically integrated midstream players. Conversely, if the estimate is downgraded or fails JORC tests, expect forced dilution or accelerated sell-down by a strategic partner seeking to reprice political and permitting risk in the region.

Key tail risks center on audit timing and geopolitical/security exposure — an independent JORC process typically takes 3–9 months plus time for any revised PEA/PFS, while permitting/financing in that jurisdiction can add 12–36 months and materially increase dilution risk. Market catalysts to watch: audit engagement announcements, independent drilling assays, formal JORC release, any Chinese state/mining house commentary, and changes in spodumene pricing that swing project economics on a 6–18 month horizon.

Key Decisions for Investors

• Tactical short KOD (AIM:KOD) on headline-driven pop: initiate a small, size-constrained short (0.25–0.5% NAV) if shares rally >20% on partner press releases; target a 30–50% downside to pre-rally price or cover at time of independent JORC engagement announcement. Rationale: headline momentum decays once independent audit timelines are disclosed; stop-loss at 25% adverse move to contain event risk.
• Risk-conditional long KOD (speculative): stagger buys into any move >40% off post-headline highs, sized 0.5–1.0% NAV, with a 12–18 month horizon and explicit exit if no JORC filing within 12 months. Reward scenario: validated resource leads to rerating or M&A interest; downside: dilution/permit delays — set mental stop at a 50% loss from entry or upon negative audit.
• Pair trade — long established lithium producer vs short KOD: long ALB (or LIT ETF) and short KOD sized to neutralize commodity exposure (e.g., dollar-neutral), horizon 6–18 months. This captures compression if juniors fail to de-risk while majors’ cash flows benefit from higher realisable spodumene output probability; aim for 2:1 reward:risk with stop if pair performance diverges >30%.
• Options hedge for volatility events: buy 6–12 month KOD put spread (long puts / sell higher-strike puts) sized to cover downside exposure from equity positions; alternatively sell covered calls on existing long positions if holding into audit outcomes to harvest premium, keeping realized upside capped to preserve capital if JORC confirms.
• Reallocate speculative capital to liquid, audited exposures: reduce weight in unvalidated juniors and increase allocation to liquid producers/ETFs (e.g., ALB, SQM, LIT) by ~2–3% of portfolio within 1 month to lower binary resource risk while retaining thematic lithium upside; monitor spot spodumene to adjust over 3–12 months.